Latest News--Shanghai Institut of Immunity and Infection, Chinese Academy of Sciences

15

2012-08

A Research Breakthrough on HIV-1 Vaccine Recommended by Faculty of 1000

On Aug.13,the research paper: HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component., Journal of Virology, 2012 (DOI: 10.3410/ f. 717952409. 793457863), was recommended as being of special significance in its field by Luigi Buonaguro and Mari...

05

2012-07

Researchers Develop a Novel Strategy to Produce HIV-1 VLP as a desirable vaccine component against HIV-1

Recently，Journal of Virology online reported a seminal work on development HIV-1 virus like particles (VLP) using stably transfected Drosophila S2 cells by Professor Paul Zhou’s laboratory at the Institut Pasteur of Shanghai, Chinese Academy of Sciences.
　　Although a recent phase III studyon ...

16

2012-05

New progress on vaccine research against Highly Pathogenic Avian Influenza H5N1 Viruses

On April 10, Journal of Virology online published an article entitled “A Triclade DNA Vaccine Designed on the Basis of a Comprehensive Serologic Study Elicits Neutralizing Antibody Responses against All Clades and Subclades of Highly Pathogenic Avian Influenza H5N1 Viruses” by Professor Paul Zh...

10

2012-05

NS1’, a newly re-identified protein in flavivirus, plays a role as caspase substrate

Japanese encephalitis virus （JEV） is a flavivirus with a complex life cycle involving mosquito vectors that mainly target birds and pigs, and causes severe encephalitis in children in Asia.
　　Under supervision of Prof. Vincent Deubel, SUN Jin, Ph.D student at Institut Pasteur of Shanghai, Chi...